Browse Category

NYSE:UNH News 25 January 2026 - 28 January 2026

Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana shares fell 21.1% to $207.93 in after-hours trading Tuesday after the Centers for Medicare & Medicaid Services proposed a 0.09% average payment increase for Medicare Advantage in 2027, far below analyst expectations. The draft also included stricter rules on diagnosis data. U.S. health insurer stocks dropped sharply, erasing billions in market value. Comments on the proposal are due by Feb. 25.
Dow Jones tumbles as UnitedHealth rout drags blue chips while Fed looms

Dow Jones tumbles as UnitedHealth rout drags blue chips while Fed looms

The Dow Jones Industrial Average fell 408.99 points to 49,003.41, led by a nearly 20% plunge in UnitedHealth after the Trump administration proposed a smaller-than-expected Medicare Advantage rate hike. The S&P 500 rose 0.4% to a record high, while the Nasdaq gained 0.9%. General Motors advanced after strong earnings and a $6 billion buyback. Investors await the Federal Reserve’s rate decision Wednesday.
UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group shares fell 19.5% to $282.90 in after-hours trading Tuesday after a weak Medicare Advantage rate proposal from the Trump administration. The company expects to lose up to 1.4 million Medicare Advantage members in 2026 and forecasts a drop in Medicaid membership. CVS and Humana shares also plunged. The government’s final Medicare Advantage rate decision is due April 6.
UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth shares fell 18.4% to $286.96 Tuesday after a U.S. proposal signaled Medicare Advantage payments would rise just 0.09% in 2027. The company warned of its first revenue drop since 1989 despite maintaining its 2026 profit outlook. CVS Health and Humana also posted sharp declines. CMS will accept comments on the proposed rates through Feb. 25.
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

The Dow Jones fell 445 points, or 0.9%, to 48,966 in early trading, dragged down by a 20% plunge in UnitedHealth after weak Medicare payment proposals and a downbeat 2026 forecast. U.S. consumer confidence dropped to its lowest since 2014. The S&P 500 and Nasdaq rose, while Humana and CVS also tumbled. Traders watched for earnings and the Fed meeting starting Tuesday.
Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

S&P 500 and Nasdaq futures rose early Tuesday, while Dow futures slipped, weighed by UnitedHealth after Washington proposed keeping Medicare Advantage payments nearly flat for 2027. Insurers fell in premarket trading. Investors awaited earnings reports and the Federal Reserve’s policy decision due Wednesday. Salesforce shares gained on news of a $5.6 billion U.S. Army contract.
Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow futures fell 40 points premarket Tuesday as UnitedHealth dropped 8.6% after a proposed Medicare Advantage rate increase came in far below expectations. S&P 500 and Nasdaq futures rose ahead of major earnings reports and the start of the Federal Reserve meeting. Salesforce gained 2.2% after landing a $5.6 billion U.S. Army contract. A partial government shutdown loomed with funding set to expire after midnight Friday.
UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth shares fell 8.3% to $322.32 in premarket trading after CMS proposed a near-flat 0.09% average payment increase for 2027 Medicare Advantage plans and stricter rules on diagnosis data. The move triggered a broad selloff in managed-care stocks, with CVS Health and Humana also dropping sharply. UnitedHealth is set to report earnings and its 2026 outlook before the market opens. CMS will accept comments on the proposal until Feb. 25.
UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth shares fell over 10% in after-hours trading Monday after U.S. officials proposed a 0.09% average payment increase for Medicare Advantage plans in 2027. The Centers for Medicare & Medicaid Services also outlined changes to risk adjustment, including limits on payments tied to certain chart reviews. CVS Health and Humana shares dropped as much as 15%. UnitedHealth reports earnings and 2026 guidance Tuesday morning.
UnitedHealth stock slips ahead of earnings: UNH investors brace for 2026 outlook

UnitedHealth stock slips ahead of earnings: UNH investors brace for 2026 outlook

UnitedHealth shares fell 1.8% to $349.74 Monday ahead of its full-year 2025 results and 2026 guidance, due before Tuesday’s market open. Analysts cite Medicare Advantage cost trends as a key focus. TipRanks projects quarterly EPS of $2.12 on $113.8 billion revenue, down year-over-year. Options traders are pricing in a 6.3% swing after earnings.
Dow Jones rises today as Fed decision and Big Tech earnings set the tone for Wall Street

Dow Jones rises today as Fed decision and Big Tech earnings set the tone for Wall Street

The Dow Jones Industrial Average rose 185.35 points, or 0.38%, to 49,284.06 by 10:32 a.m. EST, led by gains in Apple and Cisco. UnitedHealth and Boeing slipped, limiting the advance. Gold surged past $5,100 an ounce, setting a new record. Investors await the Federal Reserve meeting starting Tuesday and a U.S. funding deadline on Jan. 30.
Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

The Health Care Select Sector SPDR Fund (XLV) fell 0.5% to $157.48 Friday, with Eli Lilly down 2.1%. Johnson & Johnson and UnitedHealth posted small gains. Traders are watching obesity-drug demand and a crowded earnings calendar next week. The FDA linked ByHeart’s recalled infant formula to a multi-state botulism outbreak.
1 2 3 4 5 11

Stock Market Today

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

7 February 2026
Northern Star Resources fell 1.7% to A$26.77 Friday, extending losses as gold miners and the broader market declined. MGX Resources completed its A$50 million purchase of a 50% stake in the Central Tanami Gold Project from Northern Star. The All Ordinaries Gold index dropped 3.24%. CME Group raised COMEX gold futures margin requirements to 9% amid volatility.
PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop